USPTO serial 78533163
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
CINDY M ZELSON
CINDY M ZELSON PFIZER INC150 E 42ND STMS 26-TRADEMARK DEPTNEW YORK, NY 10017| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; central nervous system and neurological diseases and disorders; urological diseases and disorders; gastrointestinal diseases and disorders; musculoskeletal diseases and disorders; migraines, pain, inflammation and inflammatory diseases and disorders; metabolic diseases and disorders; respiratory and infectious diseases and disorders; immunological, bacterial, viral and fungal diseases and disorders; psychiatric diseases and disorders; allergies; diabetes; obesity; stroke, erectile and sexual dysfunction; and hemolytic diseases and disorders; pharmaceutical preparations, namely, osteoporosis preparations, oncological preparations, dermatological preparations, ophthalmologic preparations; smoking cessation preparations, tissue and skin repair preparations and gynecological preparations | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 17, 2007 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 6, 2007 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 14, 2007 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jan 8, 2007 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jan 8, 2007 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 13, 2006 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 13, 2006 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 13, 2006 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 17, 2006 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 25, 2005 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 5, 2005 | NPUB | NOTICE OF PUBLICATION | — |
| Aug 2, 2005 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 29, 2005 | ALIE | ASSIGNED TO LIE | — |
| Jul 25, 2005 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 20, 2005 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 28, 2004 | NWAP | NEW APPLICATION ENTERED | — |